Ergon-backed Opseo buys ZBI NRW

Stephan Patke, managing director of ZBI NRW, will remain in his management role. ZBI NRW will be incorporated into the Opseo group.

Ergon acquired a stake in Opseo, then known as Deutsche Intensivpflege Holding, in November 2016 from Delta Equity. Belgian family office Sofina also invested, along with several LPs and the company's founders. Ares and NIBC provided a €80m senior debt package and a rolling credit facility of €25m to support the deal, according to Unquote sister publication Debtwire. Ergon deployed equity from Ergon Capital Partners III, which held a final close in March 2010 on €775m.

Ergon had not responded to a request for comment at the time of publication.

Company
ZBI NRW is headquartered in Gelsenkirchen and has a further location in Marl. It will also have locations in Düsseldorf, Recklinghausen and Lünen. The company was founded in 2006 and the Gelsenkirchen facility was opened in 2018. It provides care services including artificial respiration and palliative care. The company had 56 employees in 2017, according to Northdata.

People
Opseo – Holger Eden (CEO).
Zentrum für Beatmung und Intensivpflege North Rhine-Westphalia – Stephan Patke (managing director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• DACH
• Healthcare
• Build-up
• Germany
• Ergon Capital Partners